skip navigation

S M L Text size
Home » NEI Laboratories » Laboratory of Immunology » Immunopathology Section » Murine model of von Hippel-Lindau (VHL) disease

Murine model of von Hippel-Lindau (VHL) disease

 Fundus photograph shows VHL cells in the vitrerous obscuring the view of retinal vessels and optic nerve head. Photomicrograph shows many VHL cells in the vitreous
(Left): Fundus photograph shows VHL cells in the vitrerous obscuring the view of retinal vessels and optic nerve head.
(Right): Photomicrograph shows many VHL cells in the vitreous.

We have established an ocular orthotopic xenograft model for ocular VHL (Park and Chan. Histol Histopathol 2012). Human VHL cells are inoculated into the vitreous of SCID mouse. After 2-3 weeks, the VHL cells often settle behind the lens, in the vitreous and on the retinal surface. The tumor cells may form cystic structure and express VEGF.

Last Reviewed: April 2012



Department of Health and Human Services NIH, the National Institutes of Health USA.gov